References - Therapeutic Strategies in Cancer Biology and Pathology - page 255

Vergara, D., Valente, C.M., Tinelli, A., Siciliano, C., Lorusso, V., Acierno, R., et al., 2011.
Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transi-
tion in MCF-7 cells. Cancer Lett. 310, 1-8.
Vetter, G., Saumet, A., Moes, M., Vallar, L., Le Bechec, A., Laurini, C., et al., 2010. miR-
661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to
breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers. Oncogene 29,
4436-4448.
Vinarskaja, A., Goering, W., Ingenwerth, M., Schulz, W.A., 2012. ID4 is frequently downregu-
lated and partially hypermethylated in prostate cancer. World J. Urol. 30, 319-325.
Visser-Grieve, S., Hao, Y., Yang, X., 2012. Human homolog of Drosophila expanded, hEx,
functions as a putative tumor suppressor in human cancer cell lines independently of the
Hippo pathway. Oncogene 31, 1189-1195.
Vitolo, M.I., Anglin, I.E., Mahoney, W.M., Renoud, K.J., Gartenhaus, R.B., Bachman, K.E.,
et al., 2007. The Runx2 transciption factor cooperates with the YES-associated protein
YAP65 to promote cell trnsformation. Cancer Biol. Ther. 6, 856-863.
Volinia, S., Calin, G.A., Liu, C.G., Ambs, S., Cimmino, A., Petrocca, F.A., 2006. microRNA
expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad.
Sci. U.S.A. 103, 2257-2261.
Volpe, T.A., Kidner, C., Hall, I.M., Teng, G., Grewal, S.I., Martienssen, R.A., 2002.
Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi.
Science 297, 1833-1837.
Voorhoeve, P.M., Le Sage, C., Schrier, M., Gillis, A.J.M., Stoop, H., Nagel, R.R., et al., 2006.
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular
germ cell tumors. Cell 124, 1169-1181.
Vultur, A., Buettner, R., Kowolik, C., Liang, W., Smith, D., Boschelli, F., et al., 2008. SKI-
606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human
breast cancer cells. Mol. Cancer Ther. 7, 1185-1194.
Wales, M.M., Biel, M.A., Eldeiry, W., Nelkibn, B.D., Issa, P., Cavenee, W.K., et al., 1995. p53
activates expression of HIC-1, a new candidate tumor suppressor gene on 17p13.3. Nat.
Med. 1, 570-577.
Wang, B., Matsuoka, S., Carpenter, P.B., Elledge, S.J., 2002. 53BP1, a mediator of thee DNA
damage checkpoint. Science 298, 1435-1438.
Wang, B.C., Yang, H.Z., Liu, Y.C., Jelinek, T., Zhang, L.X., Ruoslahti, E., et al., 1999.
Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display.
Biochemistry 38, 12499-12504.
Wang, D.S., Su, L., Huang, D.H., Zhang, H.Z., Shin, D.M., Chen, Z.G., 2011a. Downregulation
of E-cadherin enhances proliferation of head and neck cancer through transcriptional reg-
ulation of EGFR. Mol. Cancer 10, 116.
Wang, H., Hertlein, E., Bakkar, N., Sun, H., Acharyya, S., Wang, J., et al., 2007. NF-kappaB
regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of
myofibrillar genes. Mol. Cell Biol. 27, 4374-4387.
Wang, H., Wang, X.Q., Xu, X.P., Lin, G.W., 2010a. ID4 methylation predicts high risk of
leukemic transformation in patients with myelodysplastic syndrome. Leukemia Res. 34,
598-604.
Wang, H., Wu, J., Meng, X., Ying, X., Zuo, Y., Liu, R., et al., 2011b. MicroRNA-342 inhib-
its colorectal cancer cell proliferation and invasion by directly targeting DNA methyl-
transferase 1. Carcinogenesis 32, 1033-1042.
Wang, L., Pan, Y., Dai, J.L., 2004a. Evidence of Mkk4 pro-oncogenic activity in breast and
pancreatic tumors. Oncogene 23, 5978-5985.